US Patent 8795669 Stabilized formulations containing anti-PCSK9 antibodies
Patent 8795669 was granted and assigned to Regeneron Pharmaceuticals, Inc. on August, 2014 by the United States Patent and Trademark Office.
Is a
Date Filed
July 27, 2012
0
Date of Patent
August 5, 2014
0
Patent Application Number
13559862
0
Patent Citations Received
Patent Inventor Names
Daniel Dix
0
Scott Walsh
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8795669 Stabilized formulations containing anti-PCSK9 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
